NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI)
Who is NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI)?
The Nucleic Acid Therapeutics Initiative (NATi) is a national platform that aims to build Singapore into a regional hub for nucleic acid therapeutics (NAT) research, clinical translation, and commercialisation. NATi harnesses the potential of nucleic acids to treat diseases using RNA molecules. Thi...See more
Industry & Specialities
Others
Countries of Operation
Singapore
Headquarters:
Singapore
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2023 (3 years)
Address:
NANOS, LEVEL 5, 31 BIOPOLIS WAY, SINGAPORE 138669; SINGAPORE, SG
Employees by Department
- IT / Product (2)
- Operations (2)
- The Rest (7)
- Total (11)
Key Decision Makers
Vira Bitko
Head of Vaccines and Immunology
Emilie Soh
Program Manager
Nani Djunaidi
Project Manager
Cher Hui Goey Meng
Scientific Portfolio Manager
Employees by Seniority
C-level
0employees
Senior
5employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI) been operating for?
- What is the funding status of NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI)?
- Where is NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI)'s headquarter?
- What NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI)'s spending power?
- Does NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI) have a presence in the domain it operates in?